tradingkey.logo
tradingkey.logo
検索

TherapeuticsMD Inc

TXMD
ウォッチリストに追加
2.160USD
-0.050-2.26%
終値 07/01, 16:00ET15分遅れの株価
25.00M時価総額
138.82直近12ヶ月PER

詳細情報 TherapeuticsMD Inc 企業名

TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).

TherapeuticsMD Incの企業情報

企業コードTXMD
会社名TherapeuticsMD Inc
上場日Jan 31, 2001
最高経営責任者「CEO」Walker (Marlan D)
従業員数1
証券種類Ordinary Share
決算期末Jan 31
本社所在地951 Yamato Road, Suite 220
都市BOCA RATON
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号33431
電話番号15619611900
ウェブサイトhttps://www.therapeuticsmd.com/
企業コードTXMD
上場日Jan 31, 2001
最高経営責任者「CEO」Walker (Marlan D)

TherapeuticsMD Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
141.13K
+47.82%
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
141.13K
+47.82%
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--

よくある質問

TherapeuticsMD Incの上位5名の株主は誰ですか?

TherapeuticsMD Incの上位5名の株主は以下のとおりです。Mr. Marlan D. Walker, J.D.

TherapeuticsMD Inc(TXMD)の株式を保有している機関の数はいくつですか?

2026Q1時点で、TherapeuticsMD Incの株式を保有している機関は87社あり、保有株式の総市場価値は約3.82Mで、全体の32.99%を占めています。2025Q4と比較して、機関の持ち株は423750.00増加しています。